Shinpoong Pharmaceutical Co.,Ltd (KRX:019170)
South Korea flag South Korea · Delayed Price · Currency is KRW
10,090
+1,250 (14.14%)
At close: Aug 28, 2026

KRX:019170 Revenue

Shinpoong Pharmaceutical Co.,Ltd had revenue of 63.89B KRW in the quarter ending June 30, 2026, with 8.99% growth. This brings the company's revenue in the last twelve months to 239.07B, up 6.21% year-over-year. In the year 2025, Shinpoong Pharmaceutical Co.,Ltd had annual revenue of 234.68B with 6.15% growth.

Revenue (ttm)
239.07B
Revenue Growth
+6.21%
P/S Ratio
1.91
Revenue / Employee
295.51M
Employees
809
Market Cap
457.33B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2025234.68B13.59B6.15%
Dec 31, 2024221.09B20.87B10.42%
Dec 31, 2023200.23B-9.06B-4.33%
Dec 31, 2022209.29B20.05B10.60%
Dec 31, 2021189.24B-8.51B-4.31%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Related Stocks

Company NameRevenue
Daewoong2.12T
Dong-A Socio Holdings1.52T
Boryung1.06T
JW Holdings1.01T
Dong-A ST860.94B
JW Pharmaceutical820.86B
Huons616.80B
Ildong Pharmaceutical582.33B
Revenue Rankings